Trial · NCT02166476
Adverse events50
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 50
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | Meropenem-Vaborbactam | 24 | 272 | |
| other | Headache | Nervous system disorders | Piperacillin-Tazobactam | 12 | 273 | |
| other | Diarrhoea | Gastrointestinal disorders | Meropenem-Vaborbactam | 9 | 272 | |
| other | Diarrhoea | Gastrointestinal disorders | Piperacillin-Tazobactam | 12 | 273 | |
| other | Infusion Site Phlebitis | General disorders | Meropenem-Vaborbactam | 6 | 272 | |
| other | Infusion Site Phlebitis | General disorders | Piperacillin-Tazobactam | 2 | 273 | |
| other | Vaginal Infection | Infections and infestations | Meropenem-Vaborbactam | 1 | 272 | |
| other | Vaginal Infection | Infections and infestations | Piperacillin-Tazobactam | 6 | 273 | |
| serious | Cardiac failure congestive | Cardiac disorders | Meropenem-Vaborbactam | 1 | 272 | |
| serious | Cardiac failure congestive | Cardiac disorders | Piperacillin-Tazobactam | 0 | 273 | |
| serious | Sudden cardiac death | General disorders | Meropenem-Vaborbactam | 1 | 272 | |
| serious | Sudden cardiac death | General disorders | Piperacillin-Tazobactam | 0 | 273 | |
| serious | Bacterial sepsis | Infections and infestations | Meropenem-Vaborbactam | 0 | 272 | |
| serious | Bacterial sepsis | Infections and infestations | Piperacillin-Tazobactam | 1 | 273 | |
| serious | Pneumonia | Infections and infestations | Meropenem-Vaborbactam | 0 | 272 | |
| serious | Pneumonia | Infections and infestations | Piperacillin-Tazobactam | 1 | 273 | |
| serious | Postoperative wound infection | Infections and infestations | Meropenem-Vaborbactam | 0 | 272 | |
| serious | Postoperative wound infection | Infections and infestations | Piperacillin-Tazobactam | 1 | 273 | |
| serious | Pyelonephritis | Infections and infestations | Meropenem-Vaborbactam | 0 | 272 | |
| serious | Pyelonephritis | Infections and infestations | Piperacillin-Tazobactam | 1 | 273 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02166476/events